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Juvenile nasopharyngeal angiofibroma is a rare benign vascular tumor of the nasopharynx. Although 
the treatment of choice is surgery, there is no consensus on what is the best approach.
Aim: To compare surgical time and intraoperative transfusion requirements in patients undergoing 
endoscopic surgery versus open / combined and relate the need for transfusion during surgery with 
the time between embolization and surgery.
Material and Methods: Study descriptive, analytical, retrospective study with a quantitative approach 
developed in the Otorhinolaryngology department of a teaching hospital. Analyzed 37 patients with 
angiofibroma undergoing surgical treatment. Data obtained from medical records. Analyzed with 
tests of the Fisher-Freeman-Halton and Games-Howell. Was considered significant if p <0.05.
Study design: Historical cohort study with cross-sectional.
Results: The endoscopic approach had a shorter operative time (p <0.0001). There is less need for 
transfusion during surgery when the embolization was performed on the fourth day.
Conclusion: This suggests that the period ahead would be ideal to perform the process of 
embolization and endoscopic surgery by demanding less time would be associated with a lower 
morbidity. This study, however, failed to show which group of patients according to tumor stage 
would benefit from specific technical.
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INTRODUCTION 
The juvenile nasopharyngeal angiofibroma is 
a rare, highly vascular benign tumor of the nasopharynx. 
It comprises about 0.5% of all head and neck neoplasms. 
The incidence is 1:150.000 and it affects males in the 
14 to 25 years age group1.
Accumulation in the nucleus of β-catenin, a 
co-activator of androgenic receptors, may explain why 
this tumor selects the male sex. Normal serum levels 
of hormones in patients with juvenile nasopharyngeal 
angiofibroma corroborate this explanation2.
The typical presentation of juvenile nasopha-
ryngeal angiofibroma consists of chronic nasal block, 
epistaxis, rhinorrhea, and pain. Because of its invasive 
growth, it may lead to facial deformity, proptosis, abnor-
mal visual acuity if the orbit is involved, and paralysis 
of cranial nerves if there is intracranial involvement2,3.
A correct diagnosis is made based on the clinical 
history, the otorhinolaryngologic physical examination, 
and imaging; these procedures may avoid the need for 
biopsy, with its risk of hemorrhage. The radiologic exam 
of choice is contrasted computed tomography of the 
nose and paranasal sinuses; a tumor in the nasophar-
ynx with widening of the sphenopalatine foramen and 
marked contrast uptake may be seen. Magnetic reso-
nance imaging is used if there is cranial and orbitary 
invasion. Digital subtraction selective angiography may 
be used for the diagnosis and treatment by identifying 
the blood vessels that feed the tumor and offering the 
opportunity to embolize these vessels preoperatively3,4.
Surgery is the treatment of choice for juvenile 
nasopharyngeal angiofibroma; there are also pub-
lished descriptions of radiotherapy, hormone therapy, 
cryotherapy, electrocoagulation, and chemotherapy. 
Surgery for juvenile nasopharyngeal angiofibroma may 
be endoscopic, open, or combined5-7.
The choice of surgery is based on the extent 
of the tumor and the surgeon’s experience. Staging is 
based on any of the Radkwoski, Chandler, Sessions, 
Andrews, or Fisch classifications; the latter is used 
more often3.
Endoscopic surgery is a possible treatment 
approach when tumors are in stages I and II (Fisch) 
because the morbidity is lower.6 It may also be used 
together with traditional surgery to reduce operative 
complications and tumor recurrences8.
The purpose of this study was to compare the 
duration of surgery in each approach (open, endo-
scopic, and combined surgery), and to assess the need 
for intraoperative blood transfusion compared to the 
time elapsed since embolization.
MATERIAL AND METHOD 
A retrospective, descriptive, analytic, quantita-
tive, cross-sectional cohort study was carried out at the 
otorhinolaryngology unit of a tertiary teaching hospital.
The files of patients operated from 2001 to 2010 
were reviewed. The sample comprised 37 patients 
who underwent surgical removal of a nasopharyngeal 
angiofibroma. The inclusion criteria were a histologic 
diagnosis of nasal angiofibroma at our institution, and 
having undergone preoperative embolization with 
alcohol-polyvinyl 150-350 μm particles.
The study variables were the general charac-
teristics of patients (age and symptoms), of surgical 
procedures (duration, in minutes; transfusion; emboli-
zation; and type of approach), and tumor staging. Sur-
geries comprised two groups: endoscopic, and open/
combined surgery. The surgical approach across ten 
years took into account the surgeon’s learning curve 
for endoscopic surgery and the gradual replacement of 
the open technique.
The Fisch classification was used for staging: 
stage I (tumor limited to the nasopharynx and nasal cav-
ity with no bone destruction), stage II (tumor invading 
the pterygomaxillary fossa, the maxillary antrum, the 
ethmoid and sphenoid sinuses with bone destruction), 
stage III (tumor invading the infratemporal fossa, the 
orbit, and the parasellar area, but remaining lateral 
to the cavernous sinus), and stage IV (tumor with in-
vasion of the cavernous sinus, the optic chiasm or the 
pituitary fossa)3,9.
An analysis of the time elapsed between embo-
lization and surgery was made to identify the day that 
concentrated most patients (fourth day) and compare 
it with the remaining days.
The same surgeons carried out all surgical 
procedures (E.F.G).
The SPSS version 16.0 statistics software was ap-
plied for data processing. Simple and percentage fre-
quencies, parametric measures, means and the standard 
deviation were the basis for data analysis. The Games-
Howell test was applied to analyze the difference be-
tween mean pairs, as the variances were unequal. The 
Fisher-Freeman-Halton test was applied for association 
analyses. The significance level was p < 0.05.
RESULTS
Of 37 patients that underwent surgery for the 
nasopharyngeal angiofibroma, the mean age was 17 ± 
7 years, ranging from 8 years to 44 years. The maxillary 
artery was the blood vessel that irrigated the tumor in 
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Table 1. General characteristics of patients undergoing surgery for the treatment of juvenile nasopharyngeal angiofibroma; 
January 2001/ July 2010.
Patient Stage Technique Duration of surgery (min) Preoperative embolization (days) Transfusion (RBC concentrates)
1 III Endoscopy+Degloving 360 2 1000 ml
2 II Endoscopy+Transmaxilar 270 4 No
3 III Endoscopy+Transmaxillary 200 7 1000 ml
4 IV Endoscopy+Weber Ferguson 360 5 No
5 IV Endoscopy+Weber Ferguson 210 3 No
6 IV Degloving 170 14 No
7 II Degloving 230 10 No
8 II Degloving 230 8 No
9 II Degloving 310 5 1000 ml
10 IV Degloving 360 3 1000 ml
11 II Degloving 270 7 500 ml
12 II Degloving 195 2 500 ml
13 III Degloving 330 6 No
14 II Degloving 260 4 No
15 III Degloving 240 6 1000 ml
16 II Endoscopy 120 4 No
17 II Endoscopy 170 2 1000 ml
18 II Endoscopy 180 3 No
19 II Endoscopy 150 4 No
20 II Endoscopy 120 6 No
21 II Endoscopy 120 7 No
22 I Endoscopy 80 4 No
23 II Endoscopy 90 2 No
24 II Endoscopy 180 4 No
25 II Endoscopy 120 5 No
26 II Endoscopy 120 4 No
27 II Endoscopy 120 4 No
28 II Endoscopy 150 4 No
29 III Endoscopy 120 4 No
30 III Endoscopy 75 3 No
31 II Endoscopy 205 5 No
32 II Endoscopy 120 6 No
33 II Endoscopy 105 1 No
34 II Endoscopy 100 2 No
35 III Endoscopy 150 3 No
36 III Transmaxillary + Transfacial 440 1 4500 ml + 1 RBC concentrate
37 III Weber Ferguson 195 5 No
all cases. The ascending pharyngeal and the ophthalmic 
arteries also contributed to irrigate the tumor in one 
case, and two direct branches of the internal carotid 
fed the tumor in two other cases.
The time elapsed between embolization and 
surgery ranged from 1 to 14 days (mean 5 ± 3 days). 
The symptoms at the time of diagnosis were: epistaxis 
(96.8%), nasal block (87.8%), facial bulging (22.5%), 
nasal discharge (19.4%), ocular symptoms (16.1%), 
facial pain/headache (12.9%), and hypoacusis (3.2%).
The distribution of patients according to tumor 
staging was as follows: stage I, one patient (3%); stage 
II, 23 patients (62%); stage III, nine patients (24%); and 
stage IV, four patients (11%) (Table 1).
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Intraoperative transfusions were needed in nine 
patients. Of these, eight underwent open surgery and 
one underwent endoscopic surgery (Table 1).
A comparison of patients in which embolization 
was done four days before surgery (most patients) 
with patients in which embolization was done on other 
days revealed that intraoperative transfusions were not 
required when embolization was done specifically on 
this day (p>0.05) (Table 2).
A comparison of the mean duration of surgery 
among the surgical procedures showed that endoscopy 
required less time than open/combined surgery (Table 
3).
Most of the patients of all tumor stages (except 
for stage I) that required transfusions during surgery 
belonged to the open/combined surgery group. The 
mean duration of surgery was higher in this group com-
pared to the group of patients that underwent endos-
copy. There was, however, no significant relationship 
between tumor stage and the need for intraoperative 
transfusion (Table 4).
DISCUSSION
Prior embolization of the tumor makes it easier to 
identify anatomical landmarks during surgery without 
significant bleeding, thereby facilitating the procedure. 
Consequently, prior embolization also helps reduce 
surgical morbidity6.
Published papers have shown that the ideal time 
for embolization of tumors is one to three days before 
endoscopy8. However, our results showed that blood 
transfusion was less necessary when embolization 
was done four days before surgery compared to other 
number of days before; furthermore, surgeons found 
that the four day time period yielded a better cleavage 
plane and less perioperative bleeding.
Endoscopic surgery has many advantages com-
pared to the traditional approaches. The main one is that 
a wider view of the tumor and anatomical landmarks 
from several angles becomes possible, which yields a 
better visualization of the interface between the tumor 
and adjacent soft tissues and bone. The result is a more 
accurate and complete dissection and better control of 
bleeding4,10. A further advantage of endoscopic surgery 
is that incisions on the skin and mucosa and facial os-
Table 2. Need for intraoperative transfusion versus time since tumor embolization; January 2001 / July 2010. 
Transfusion Time (days) * p=0.079
Yes
1
1 50%
2
3 60%
3
1 25%
4
-
5
1 20%
6
1 25%
7
2 33.3%
8
-
10
-
14
-
No 1 50% 2 40% 4 75% 10* 100% 4 80% 3 75% 1 66.6% 1 100% 1 100% 1 100%
* Fisher-Freeman-Halton test
Table 3. Comparison of the mean duration of surgery according 
to each type of procedure; January 2001 / July 2010.
Surgery Duration of surgery (min).
Type of Surgery N %
Mean ± Standard Deviation 
**p < 0.00012
Open / Combined 17 45.9 272.35 ± 75.93**
Endoscopy 20 54.1 129.75 ± 34.70**
** Games-Howell test
Table 4. Association between the type of surgery and tumor 
staging; January 2001 / July 2010.
Stage / Surgery
Need for 
transfusion
Yes No
Duration of surgery
Mean (MIN) ± SD
Stage I
Open / Combined (n= 0)
- -
Endoscopy (n=1) - 1(100%) 80.00 ± 00.00
Open / Combined (n= 7)
3 (43%) 4(57%) 
* p=0.061
252.14 ± 37.17 
**p<0.0001
Endoscopy (n=16)
1 (6.2%) 
15(93.8%)
135.63 ± 33.00
Stage III
Open / Combined (n= 6)
2 (33.3%) 
4 (66.6%) 
*p=0.500
294.17 ± 98.51 
**p<0.0001
Endoscopy (n=3) - 3 (100%) 115.00 ±37.74
Stage IV
Open / Combined (n= 4)
1 (25%) 3(75%) 275.00 ± 99.49
Endoscopy (n=0) - - -
* Fisher-Freeman-Halton test ** Games-Howell test
teotomies are unnecessary, thereby affecting less the 
growth of the midface of adolescents. Incisions and 
closure is not needed, which reduces the duration of 
surgery and postoperative complications, such as dys-
esthesia, pain, and trismus, which occur in some of the 
external approaches4.
Yiotakis et al. 9 studied the postoperative com-
plications of 20 patients in which a nasopharyngeal 
angiofibroma was removed and concluded that the 
endoscopic approach after embolization is safe, effec-
tive, and associated with fewer complications; it is thus 
ideal for tumors at initial stages. In our series, the mean 
duration of surgery for endoscopy was 107.7 minutes; 
for open procedures it was over 200 minutes (203 
minutes for degloving, and 270 minutes for transpalatine 
surgery). Our findings corroborate these findings; our 
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mean duration for endoscopy was 130 minutes, and for 
open surgery it was 270 minutes, suggesting that the 
latter could cause more morbidity.
Among our patients, only one of nine patients that 
required blood transfusion had undergone endoscopic 
surgery. We found no relationship as to which would 
be the best technique for a given stage when analyzing 
the need for blood transfusions and tumor staging; the 
patients were distributed non-homogeneously within 
both surgery groups.
A relatively low blood loss during endoscopic 
procedures may occur due to the careful nature of 
dissection. Even small amounts of bleeding limit the sur-
geon’s endoscopic view, so special attention should be 
given to hemostasis for satisfactory results. Furthermore, 
most of the blood loss in open approaches occurs be-
cause of incisions and osteotomies for surgical access5.
Pryor et al.5 studied 54 patients in which naso-
pharyngeal angiofibromas were removed; open surgery 
was done in 49 patients and endoscopic surgery was 
done in five patients. The authors found that there was 
less intraoperative bleeding, a shorter hospital stay, 
and fewer complications and recurrences in patients 
that underwent endoscopic surgery. The authors also 
suggested that tumors involving the ethmoid, the maxil-
lary sinus, the sphenoid sinus, and stage I and II (Fisch) 
can be operate by endoscopy. Tumors that involve 
the orbit or the cavernous sinus require an intra- and 
extracranial approach.
Midfacial degloving is a reasonable choice for 
nearly all advanced tumors – Fisch’s stage IV – as it is 
useful for providing a good surgery view during surgery, 
esthetic results, and lower morbidity; if necessary, it may 
be combined with other approaches or craniotomy11,12.
The contraindications against endoscopy are 
stage IV and some stage III nasopharyngeal angiofi-
bromas, which extend to the mid-cranial fossa. It is 
advantageous to combine midfacial degloving with 
endoscopy when removing tumors that extend through 
the anterior portion of the cribbous lamina, and also to 
eventually correct cerebrospinal fluid leaks13.
Extension of the tumor to the lateral infratemporal 
fossa, the sellar area, and areas adjacent to the optic 
nerve is a challenge for endoscopic resection. When 
tumors invade these areas, the surgical view is limited 
even in open procedures and tumors are hard to re-
sect. Endoscopy provides lighting, amplification, and 
multiangle visualization, which may facilitate removal 
of tumors that are adjacent to these vital areas. Asso-
ciating open surgery with endoscopy is advantageous 
in this context, as the benefits of both approaches are 
explored, and the possibility of tumor recurrence is 
reduced8,14.
Still, Carrau et al.15 noted that tumors may be 
treated by endoscopic surgery alone when the ptery-
gopalatine and infratemporal fossae are involved.
This comparison of our findings with the litera-
ture aimed to foster debates on this topic. There is no 
consensus on when to carry out embolism or which is 
the best surgical approach for each tumor stage.
CONCLUSION 
We found that the mean duration of surgery was 
shorter when endoscopy was the chosen technique 
compared to open approaches, which is possibly due 
to lower morbidity of endoscopy. There was less need 
for blood transfusion in patients that underwent em-
bolization four days prior to surgery.
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